1-20 of 36
Term: Health Outcome Measures
Volume: 20
Issue: suppl_6
Journal Article
HOUT-16. THE COST EFFECTIVENESS OF TUMOR TREATING FIELDS TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA BASED ON THE EF-14 TRIAL
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi116, https://doi.org/10.1093/neuonc/noy148.484
Published: 05 November 2018
Journal Article
HOUT-20. AN ONLINE CALCULATOR FOR THE PREDICTION OF SURVIVAL AND ADJUVANT TREATMENT BENEFIT IN GLIOBLASTOMA PATIENTS
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi117, https://doi.org/10.1093/neuonc/noy148.488
Published: 05 November 2018
Journal Article
HOUT-23. ASSOCIATION BETWEEN TREATMENT FACILITY VOLUME AND MORTALITY IN PATIENTS WITH GLIOBLASTOMA (GBM): A LARGE NATIONAL ANALYSIS
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi118, https://doi.org/10.1093/neuonc/noy148.491
Published: 05 November 2018
Journal Article
HOUT-24. DURAMATRIX-ONLAY® PLUS IN CRANIAL SURGERY IS ASSOCIATED WITH AN ACCEPTABLE COMPLICATION PROFILE: A CASE SERIES
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi118, https://doi.org/10.1093/neuonc/noy148.492
Published: 05 November 2018
Journal Article
HOUT-27. THE CHALLENGE OF HEALTH UTILITY VALUES FOR GLIOBLASTOMA PATIENTS WITH LONG-TERM SURVIVAL
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi119, https://doi.org/10.1093/neuonc/noy148.495
Published: 05 November 2018
Journal Article
HOUT-31. CARE PATTERNS AND TREATMENT EFFICACY: A CLINICAL SERIES OF PRIMARY GLIOBLASTOMA WITH AN EMPHASIS ON OLDER ADULTS
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi120, https://doi.org/10.1093/neuonc/noy148.499
Published: 05 November 2018
Journal Article
HOUT-32. SIGNIFICANCE OF COMORBIDITY INDEX IN ELDERLY PATIENTS WITH GLIOBLASTOMA
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi120, https://doi.org/10.1093/neuonc/noy148.500
Published: 05 November 2018
Journal Article
HOUT-36. INSTITUTIONAL COMPLIANCE WITH TUMOR TREATING FIELDS FOR GLIOBLASTOMA
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi121, https://doi.org/10.1093/neuonc/noy148.504
Published: 05 November 2018
Journal Article
HOUT-03. SCREENING FOR MOOD DISTURBANCE IN LONG-TERM CENTRAL NERVOUS SYSTEM (CNS) TUMOR SURVIVORS USING PATIENT REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM (PROMIS): A NEURO-ONCOLOGY BRANCH NATURAL HISTORY STUDY (NOB-NHS) REPORT
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi113, https://doi.org/10.1093/neuonc/noy148.471
Published: 05 November 2018
Journal Article
HOUT-04. DEMOGRAPHIC PROFILES, MANAGEMENT AND CLINICAL OUTCOMES OF GLIOBLASTOMA PATIENTS TREATED AT ST. LUKE’S MEDICAL CENTER- PHILIPPINES
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi113, https://doi.org/10.1093/neuonc/noy148.472
Published: 05 November 2018
Journal Article
HOUT-07. AN EVALUATION OF THE TREATMENT COURSE IN PATIENTS WITH GLIOBLASTOMA MULTIFORME
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi114, https://doi.org/10.1093/neuonc/noy148.475
Published: 05 November 2018
Journal Article
HOUT-10. SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) TREATMENT IS ASSOCIATED WITH IMPROVED SURVIVAL AMONG ELDERLY PATIENTS DIAGNOSED WITH GLIOBLASTOMA
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi115, https://doi.org/10.1093/neuonc/noy148.478
Published: 05 November 2018
Journal Article
HOUT-14. HOMOLOGOUS RECOMBINATION DEFICIENCY IN PATIENTS WITH HIGH GRADE GLIOMAS
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi116, https://doi.org/10.1093/neuonc/noy148.482
Published: 05 November 2018
Journal Article
HOUT-01. A RETROSPECTIVE ANALYSIS OF OUTCOMES WITH TEMOZOLOMIDE AS INITIAL TREATMENT OF GRADE 2 OLIGODENDROGLIOMA
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi113, https://doi.org/10.1093/neuonc/noy148.469
Published: 05 November 2018
Journal Article
HOUT-02. VARIATION IN POST-OPERATIVE LENGTH OF STAY IN NEURO-ONCOLOGIC SURGERY
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi113, https://doi.org/10.1093/neuonc/noy148.470
Published: 05 November 2018
Journal Article
HOUT-06. PATTERN OF LOW FIELD INTENSITY RECURRENCE IN HIGH-GRADE GLIOMAS FOLLOWING TUMOR TREATMENT FIELD THERAPY
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi114, https://doi.org/10.1093/neuonc/noy148.474
Published: 05 November 2018
Journal Article
HOUT-08. COMORBID MEDICAL CONDITIONS AS PREDICTORS OF OVERALL SURVIVAL IN SURGICAL PATIENTS WITH GLIOBLASTOMA
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi114, https://doi.org/10.1093/neuonc/noy148.476
Published: 05 November 2018
Journal Article
HOUT-09. USING THE ASCO AND ESMO FRAMEWORKS TO ASSESS THE CLINICAL VALUE OF TUMOR TREATING FIELDS FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi114–vi115, https://doi.org/10.1093/neuonc/noy148.477
Published: 05 November 2018
Journal Article
HOUT-11. ECONOMIC IMPACT OF SODIUM THIOSULFATE ON CISPLATIN-INDUCED HEARING LOSS
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi115, https://doi.org/10.1093/neuonc/noy148.479
Published: 05 November 2018
Journal Article
HOUT-17. ELDERLY PATIENTS >65YEARS OF AGE WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME GAIN LIFE TIME FROM TREATMENT WITH TUMOR TREATING FIELDS AND TEMOZOLOMIDE
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi116, https://doi.org/10.1093/neuonc/noy148.485
Published: 05 November 2018
